CBS San

CBS San Francisco reporter Juliette Goodrich joined the station in 1997 and has performed various anchoring and reporting assignments throughout her career. She is a Bay Area native, graduating from U.C. Davis with a degree in Communications and has received multiple Emmy Awards for her work. Juliette's journalism career began in the early 90s, reporting for Channel 30 in Pleasanton before moving on to other local and national news stations. Throughout her tenure at CBS San Francisco, she has covered a wide range of stories and received numerous awards for her reporting. In addition to her professional accomplishments, Juliette is involved in various community organizations and has written several children's books with proceeds benefiting local reading programs.

95%

The Daily's Verdict

This author is known for its high journalistic standards. The author strives to maintain neutrality and transparency in its reporting, and avoids conflicts of interest. The author has a reputation for accuracy and rarely gets contradicted on major discrepancies in its reporting.

Bias

100%

Examples:

No current examples available.

Conflicts of Interest

100%

Examples:

No current examples available.

Contradictions

50%

Examples:

  • The article discusses the safety of the new COVID variant FLiRT[
  • US World Politics, Entertainment, HealthWatch, MoneyWatch, Investigations, Crime, Space, Sports and Local News channels are mentioned in the article

Deceptions

100%

Examples:

No current examples available.

Recent Articles

New Covid FLiRT Variants: Dominant Strains in US and Europe, Potential Impact on Vaccine Effectiveness

New Covid FLiRT Variants: Dominant Strains in US and Europe, Potential Impact on Vaccine Effectiveness

Broke On: Wednesday, 22 May 2024 New Covid FLiRT Variants, KP.2 and KP.1.1, account for over 35% of US Covid-19 cases as of May 2024, surpassing the previously dominant JN.1 strain with similar mutations. These new variants have spread to Europe but currently cause no more severe disease than previous strains, although they may evade immunity from vaccines or past infections. Health officials closely monitor their spread and assess vaccine effectiveness against them.